1. USFDA Inspection due week ending 23 Oct 2016
2. Stock split 5:1 on 18th Oct 2016
3. Q2 results to be published in 1st week of Nov
Technically, it is able to over come resistance of 1364 but facing lot of supply around 1450 levels. I expect the stock to touch new highs in coming months.
No new investment is suggest at this point in time but a good stock to watchout for.
Disc: Holding some shares in the company